|
|
Martinstrase 10-12
Aachen, 52062 Germany
phone:+(49) 241-4453-0
fax:+49-(0)241-4453-100
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.paion.de
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Focused on the clinical development of drug candidates for diseases or interventions with unmet need. |
|
| Management |
| Dr. Wolfgang S�hngen, Chief Executive Officer, Founder; Alexander Vos, Chief Operating Officer; Dr. Mariola S�hngen, Chief Medical Officer, Founder; Bernhard Hofer, Chief Financial Officer; PD Dr. Stephan Wnendt, Managing Director of PAION Deutschland GmbH |
| |
|
|
| |
|
| Keywords |
| stroke, thrombolytic, ptotein, ischaemic, blood, clot |
|
|
|
| Description |
|
PAION GmbH is dedicated to the development of innovative therapeutic products for the treatment of stroke. |
|
| Products / Services |
PAION's lead compound, Desmoteplase, is a recombinant thrombolytic protein, currently in a global Phase II trial for acute ischaemic stroke. Further highly promising recombinant therapeutic proteins are in preclinical investigations.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members